ArticlePathogens and disease2025
Primary human nasal, nasopharyngeal, and bronchial epithelia show distinct immune responses to various pathogens.
Article in Pathogens and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Human in vitro airway models to assess point-of-contact respiratory toxicity of surfactants and derive human equivalent concentrations after single dose exposure.Toxicological sciences : an official journal of the Society of Toxicology · 2026Article
- Tonic and early interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures.Journal of virology · 2026Article
- Streptococcus pneumoniae adaptation to nutrient deprivation and immune modulation drives upper respiratory tract colonization.The ISME journal · 2026Article
- Article
- Impact of host factors and invasive meningococci on bacterial adhesion, proliferation, primary nasal epithelial barrier function, and immune response.Microbiology spectrum · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The respiratory epithelium serves as initial defense against airborne pathogens through its barrier function and induction of immune responses. To study epithelial-pathogen interactions, we used primary epithelial models that closely resembled the epithelia of the airways, for which we collected nasal (n = 7), nasopharyngeal (n = 3), and bronchial (n = 4) epithelial cells from different donors. We cultured these epithelial cells on an air-liquid interface and evaluated their differentiation status. To assess how the different epithelial models respond to distinct types of exposures, the cells were stimulated with IFN-γ, Streptococcus pneumoniae, Neisseria meningitidis, or respiratory syncytial virus (RSV) for 72 h. The nasopharyngeal epithelium was distinct from nasal and bronchial cells with respect to morphology, pathogen load, and induction of cytokine responses, while nasal and bronchial epithelial cells had similar, but not identical cytokine profiles. Each tissue type and stimulus showed specific cytokine patterns. Interestingly, donor-specific differences for IFN-λ2,3 and IL-6 responses were found during meningococcal and RSV infections. Our data highlight morphological differences and a broad variety of epithelial cytokine responses in the different regions of the upper respiratory tract. These different epithelial models will help unravel why some pathogens target specific respiratory regions and why certain individuals are more susceptible to infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.